Key result
Transcatheter aortic valve implantation had a 10.2% all-cause mortality rate at 12 months, with acute kidney injury, bleeding, and periprocedural stroke associated with higher mortality.
Why the study?
Despite advancements in devices and techniques, transcatheter aortic valve implantation remains associated with complications impacting outcomes, and the VARC-3 criteria were introduced to better classify these complications.
Meta-Analysis (n=73,588)
TAVI demonstrates high procedural success but carries non-negligible complication rates under the updated VARC-3 criteria, with acute kidney injury, bleeding, and non-structural valve dysfunction predicting higher mortality.
BACKGROUND: Despite continuous advancements in devices and techniques, transcatheter aortic valve implantation remains associated with complications impacting outcomes. In 2021, the Valve Academic Research Consortium (VARC) introduced the VARC-3 criteria to better classify procedural complications. METHODS: We conducted a systematic review and meta-analysis of studies reporting transcatheter aortic valve implantation-related complications using VARC-3 definitions between 2021 and 2025. The primary end point was all-cause mortality at latest follow-up. Secondary end points included major VARC-3 complications and predictors of adverse events. RESULTS: A total of 57 studies with 73 588 patients were included. The cohort had a mean age of 81.7 years, 51.7% were women, and most had preserved ejection fraction (55.5%) and low-to-moderate surgical risk (Society of Thoracic Surgeons [STS] predicted risk of mortality [PROM] 4.1%). Technical and 30-day device success rates were 95% and 90%, respectively; early safety rate at 30 days was 66%. At average 12 months follow-up, all-cause mortality was 10.2%. The most common complication was permanent pacemaker implantation (13%), followed by type 2 or greater bleeding (9.7%), acute kidney injury stage 3-4 (4.7%), major vascular events (4.3%), and stroke (3.0%). Moderate/severe paravalvular regurgitation and patient-prosthesis mismatch occurred in 4% and 8%, respectively. Study-level pooled predictor analyses showed that acute kidney injury, type 2 or greater bleeding, paravalvular regurgitation, non-structural valve dysfunction, and higher STS score were associated with higher mortality, while eccentric/severe aortic valve calcification was associated with significant paravalvular regurgitation. CONCLUSIONS: Transcatheter aortic valve implantation shows high procedural success but non-negligible complication rates under VARC-3 criteria. acute kidney injury, type 2 or greater bleeding, NSVD, periprocedural stroke and myocardial infarction after transcatheter aortic valve implantation were associated with higher mortality.
No takes yet. Share an insight, caveat, or question.
Giacobbe et al. (2026) conducted a meta-analysis in Transcatheter aortic valve implantation (n=73,588). Transcatheter aortic valve implantation was evaluated on All-cause mortality at latest follow-up. Transcatheter aortic valve implantation had a 10.2% all-cause mortality rate at 12 months, with acute kidney injury, bleeding, and periprocedural stroke associated with higher mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: